11-208916-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001286134.2(RIC8A):c.62C>T(p.Ala21Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000295 in 1,610,492 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001286134.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIC8A | NM_001286134.2 | c.62C>T | p.Ala21Val | missense_variant | 1/10 | ENST00000526104.6 | NP_001273063.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIC8A | ENST00000526104.6 | c.62C>T | p.Ala21Val | missense_variant | 1/10 | 1 | NM_001286134.2 | ENSP00000432008.1 |
Frequencies
GnomAD3 genomes AF: 0.000119 AC: 18AN: 151878Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000112 AC: 27AN: 240218Hom.: 1 AF XY: 0.000137 AC XY: 18AN XY: 131640
GnomAD4 exome AF: 0.000313 AC: 457AN: 1458614Hom.: 2 Cov.: 32 AF XY: 0.000288 AC XY: 209AN XY: 725436
GnomAD4 genome AF: 0.000119 AC: 18AN: 151878Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74184
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.62C>T (p.A21V) alteration is located in exon 1 (coding exon 1) of the RIC8A gene. This alteration results from a C to T substitution at nucleotide position 62, causing the alanine (A) at amino acid position 21 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at